• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

妊娠 20 周前因红细胞同种免疫导致的极早期胎儿贫血的处理。

Management of very early fetal anemia resulting from red-cell alloimmunization before 20 weeks of gestation.

机构信息

From the Service de Gynécologie Obstétrique and Centre National de Référence en Hémobiologie Périnatale, Hôpital Saint Antoine-Paris, Paris, France.

出版信息

Obstet Gynecol. 2011 Dec;118(6):1323-1329. doi: 10.1097/AOG.0b013e318235e3bb.

DOI:10.1097/AOG.0b013e318235e3bb
PMID:22105262
Abstract

OBJECTIVE

To evaluate the results of management of very early fetal anemia (before 20 weeks of gestation) in cases of red-cell alloimmunization.

METHODS

Retrospective study of the outcome of all in utero transfusions performed before 20 weeks of gestation and all pregnancies requiring an in utero transfusion before 20 weeks in our reference center from January 1990 through August 2011 in cases with severe alloimmunization.

RESULTS

Twenty-five in utero transfusions were performed in 18 pregnancies in 16 patients during the study period. A vascular access was performed successfully in 22 of the 24 cases in which it was attempted. An intraperitoneal transfusion was necessary in two cases. Two in utero deaths attributable to the intravascular procedure occurred during attempts before 18 weeks of gestation and another, not associated with a transfusion, at 29 weeks. The overall survival rate was 83.3% (compared with 88.0% when the first in utero transfusion took place before 22 weeks). The risk of fetal loss for each transfusion was 8.0% before 20 weeks and 6.3% before 22 weeks. An intraperitoneal transfusion at 17 2/7 weeks allowed one fetus to survive until the first intravascular in utero transfusion could take place at 18 2/7 weeks.

CONCLUSION

Fetal anemia before 20 weeks remains at high risk of lethal complications compared with later gestational ages. Technical difficulties in a vascular access are mainly encountered before 18 weeks of gestation. At an earlier gestational age, intraperitoneal transfusion may gain the days necessary to perform an intravascular transfusion more safely.

LEVEL OF EVIDENCE

III.

摘要

目的

评估红细胞同种免疫情况下极早期胎儿贫血(20 周妊娠前)的处理结果。

方法

回顾性分析 1990 年 1 月至 2011 年 8 月期间本中心严重同种免疫病例中所有在 20 周妊娠前进行的宫内输血和所有在 20 周妊娠前需要宫内输血的妊娠结局。

结果

在研究期间,16 例患者的 18 例妊娠中进行了 25 次宫内输血。在尝试进行血管通路的 24 例中,22 例成功。有 2 例需要进行腹腔内输血。在 18 周前尝试时,有 2 例因血管内操作导致宫内死亡,另 1 例在 29 周时未与输血相关的宫内死亡。总的存活率为 83.3%(当第一次宫内输血发生在 22 周前时为 88.0%)。在 20 周前,每次输血的胎儿丢失风险为 8.0%,在 22 周前为 6.3%。在 17 2/7 周时进行的腹腔内输血使 1 个胎儿能够存活到 18 2/7 周时进行第一次血管内宫内输血。

结论

与妊娠后期相比,20 周前的胎儿贫血仍然存在高致死性并发症的风险。血管通路的技术困难主要发生在 18 周前。在更早的妊娠周数时,腹腔内输血可能为更安全地进行血管内输血争取到必要的时间。

证据水平

III。

相似文献

1
Management of very early fetal anemia resulting from red-cell alloimmunization before 20 weeks of gestation.妊娠 20 周前因红细胞同种免疫导致的极早期胎儿贫血的处理。
Obstet Gynecol. 2011 Dec;118(6):1323-1329. doi: 10.1097/AOG.0b013e318235e3bb.
2
In utero treatment of severe fetal anemia resulting from fetomaternal red blood cell incompatibility: a comparison of simple transfusion and exchange transfusion.宫内治疗胎儿母红细胞不相容性导致的严重胎儿贫血:单纯输血与换血输血的比较
Eur J Obstet Gynecol Reprod Biol. 2016 Jun;201:85-8. doi: 10.1016/j.ejogrb.2016.03.037. Epub 2016 Apr 1.
3
Early procedure-related complications of fetal blood sampling and intrauterine transfusion for fetal anemia.胎儿血液采样和宫内输血治疗胎儿贫血的早期与操作相关的并发症。
Acta Obstet Gynecol Scand. 2012 Apr;91(4):458-62. doi: 10.1111/j.1600-0412.2011.01353.x. Epub 2012 Feb 22.
4
Management and outcome of pregnancies in women with red cell isoimmunization: a 15-year observational study from a tertiary care university hospital.红细胞同种免疫妇女妊娠的管理和结局:来自一所三级大学附属医院的 15 年观察性研究。
BMC Pregnancy Childbirth. 2019 Oct 15;19(1):356. doi: 10.1186/s12884-019-2525-y.
5
Postponing Early intrauterine Transfusion with Intravenous immunoglobulin Treatment; the PETIT study on severe hemolytic disease of the fetus and newborn.静脉注射免疫球蛋白治疗下延迟早期宫内输血;胎儿和新生儿严重溶血病的 PETIT 研究。
Am J Obstet Gynecol. 2018 Sep;219(3):291.e1-291.e9. doi: 10.1016/j.ajog.2018.06.007. Epub 2018 Jun 11.
6
An audit of outcome in intravascular transfusions using the intrahepatic portion of the fetal umbilical vein compared to cordocentesis.一项关于使用胎儿脐静脉肝内部分进行血管内输血与脐静脉穿刺术的结局审计。
Fetal Diagn Ther. 2006;21(3):272-6. doi: 10.1159/000091355.
7
Clinical Characteristics of Jra Alloimmunization in Pregnancy: A Case Series.妊娠期 Jra 同种免疫的临床特征:病例系列。
Fetal Diagn Ther. 2019;46(6):433-439. doi: 10.1159/000501517. Epub 2019 Aug 21.
8
Fetal Intracardiac Transfusions in Hydropic Fetuses with Severe Anemia.重度贫血水肿胎儿的胎儿心脏内输血
Fetal Diagn Ther. 2015;38(1):61-4. doi: 10.1159/000369798. Epub 2015 Feb 3.
9
Is intrauterine exchange transfusion a safe procedure for management of fetal anaemia?宫内换血术对于治疗胎儿贫血是一种安全的操作吗?
Eur J Obstet Gynecol Reprod Biol. 2014 Aug;179:83-7. doi: 10.1016/j.ejogrb.2014.05.008. Epub 2014 May 20.
10
Procedure-related complications and perinatal outcome after intrauterine transfusions in red cell alloimmunization in Stockholm.在斯德哥尔摩的红细胞同种免疫中,宫内输血后的与操作相关的并发症和围产儿结局。
Fetal Diagn Ther. 2011;30(4):266-73. doi: 10.1159/000328683. Epub 2011 Oct 19.

引用本文的文献

1
FcRn Blockade as a Targeted Therapeutic Strategy in Antibody-Mediated Autoimmune Diseases: A Focus on Warm Autoimmune Hemolytic Anemia.FcRn阻断作为抗体介导的自身免疫性疾病的靶向治疗策略:聚焦温抗体型自身免疫性溶血性贫血
Antibodies (Basel). 2025 Aug 1;14(3):65. doi: 10.3390/antib14030065.
2
Targeting the Neonatal Fc Receptor in Autoimmune Diseases: Pipeline and Progress.自身免疫性疾病中靶向新生儿Fc受体:研发进程与进展
BioDrugs. 2025 May;39(3):373-409. doi: 10.1007/s40259-025-00708-2. Epub 2025 Mar 29.
3
Design of a Phase 3, Global, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn.
一项关于尼泊卡利单抗用于有胎儿及新生儿严重溶血病风险妊娠的3期全球多中心随机安慰剂对照双盲研究的设计
Am J Perinatol. 2025 May;42(7):842-853. doi: 10.1055/a-2404-8089. Epub 2024 Aug 28.
4
Case report: Double filtration plasmapheresis (DFPP) for severe rhesus-D alloimmunization in two pregnant patients.病例报告:两名孕妇严重恒河猴-D同种免疫的双重滤过血浆置换术(DFPP)
Front Pediatr. 2023 Apr 11;11:1147675. doi: 10.3389/fped.2023.1147675. eCollection 2023.
5
Hemolytic disease of the fetus and newborn: systematic literature review of the antenatal landscape.胎儿和新生儿溶血病:产前全景的系统文献回顾。
BMC Pregnancy Childbirth. 2023 Jan 7;23(1):12. doi: 10.1186/s12884-022-05329-z.
6
Intrauterine transfusion in 103 fetuses with severe anemia caused by parvovirus infection. A multicenter retrospective study.103 例因微小病毒感染导致严重贫血的胎儿的宫内输血。一项多中心回顾性研究。
Arch Gynecol Obstet. 2023 Jul;308(1):117-125. doi: 10.1007/s00404-022-06712-z. Epub 2022 Aug 2.
7
Efficacy of Antenatal Intravenous Immunoglobulin Treatment in Pregnancies at High Risk due to Alloimmunization to Red Blood Cells.产前静脉注射免疫球蛋白治疗因红细胞同种免疫而处于高危状态的妊娠的疗效
Transfus Med Hemother. 2018 Nov;45(6):429-436. doi: 10.1159/000490154. Epub 2018 Oct 31.
8
Complications of intrauterine intravascular blood transfusion: lessons learned after 1678 procedures.宫内血管内输血的并发症:1678例手术之后的经验教训
Ultrasound Obstet Gynecol. 2017 Aug;50(2):180-186. doi: 10.1002/uog.17319.